Efgartigimod Alfa + Ravulizumab Interaction

Moderateinteraction on record

Description

Neonatal Fc receptor blocker that may lower systemic exposures and reduce effectiveness of ULTOMIRIS; closely monitor for reduced effectiveness.

Mechanism

Lowers systemic exposures of ravulizumab

Source: NLP:ravulizumab